Clinical Trial Update: T Wave Alternans in Hemodialysis

View source ↗

Summary

A ClinicalTrials.gov entry reports a completed study on T Wave Alternans in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• End-stage Renal Disease
• Heart Failure

Snippet

Sponsor: Indiana University School of Medicine | Conditions: End Stage Renal Disease, Coronary Heart Disease | Status: COMPLETED